Skip to content

Survival Outcomes Based on Axillary Surgery in Ductal Carcinoma In Situ : A Nationwide Study From the Korean Breast Cancer Society

Document Type
Publications · Journal Article
Registered DB
KCISCIEScopus
Journal Ranking
JCR Q3Scopus Q3KCI Q2
Journal
JOURNAL OF BREAST CANCER27(1) · pp.1 · 2024
Citation
Web of Science 0Scopus 2KCI 0
FWCI (Scopus)
0.11
JCR IF
JCR 2023 2.2
ISSN
1738-6756

Authors

  1. Kim, Bong KyunFirst authorCatholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea
  2. Woo, JoohyunEwha Womans Univ, Ewha Womans Univ Coll Med, Dept Surg, Mokdong Hosp, Seoul, South Korea
  3. Lee, JeeyeonKyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea
  4. Kang, EunhyeSeoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
  5. Baek, Soo YeonAjou Univ, Ajou Univ Med Ctr, Dept Surg, Sch Med, Suwon, South Korea
  6. Lee, SeokwonPusan Natl Univ Hosp, Pusan Natl Univ Sch Med, Biomed Res Inst, Dept Surg, Busan, South Korea
  7. Lee, Hyouk JinSaegyaero Hosp, Breast Thyroid Ctr, Busan, South Korea
  8. Lee, JinaCatholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea
  9. Sun, Woo YoungCorresponding authorCatholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea

Abstract

Purpose In total mastectomy (TM), sentinel lymph node biopsy (SLNB) is recommended but can be omitted for breast-conserving surgery (BCS) in patients with ductal carcinoma in situ (DCIS). However, concerns regarding SLNB-related complications and their impact on quality of life exist. Consequently, further research is required to evaluate the role of axillary surgeries, including SLNB, in the treatment of TM. We aimed to explore the clinicopathological factors and outcomes associated with axillary surgery in patients with a final diagnosis of pure DCIS who underwent BCS or TM. Methods We retrospectively analyzed large-scale data from the Korean Breast Cancer Society registration database, highlighting on patients diagnosed with pure DCIS who underwent surgery and were categorized into two groups: BCS and TM. Patients were further categorized into surgery and non-surgery groups according to their axillary surgery status. The analysis compared clinicopathological factors and outcomes according to axillary surgery status between the BCS and TM groups. Results Among 18,196 patients who underwent surgery for DCIS between 1981 and 2022, 11,872 underwent BCS and 6,324 underwent TM. Both groups leaned towards axillary surgery more frequently for large tumors. In the BCS group, clinical lymph node status was associated with axillary surgery (odds ratio, 11.101; p = 0.003). However, in the TM group, no significant differences in these factors were observed. Survival rates did not vary between groups according to axillary surgery performance. Conclusion The decision to perform axillary surgery in patients with a final diagnosis of pure DCIS does not affect the prognosis, regardless of the breast surgical method. Furthermore, regardless of the breast surgical method, axillary surgery, including SLNB, should be considered for high-risk patients, such as those with large tumors. This may reduce unnecessary axillary surgery and enhance the patients’ quality of life.

Keywords

CarcinomaIntraductalNoninfiltratingMastectomySentinel Lymph NodeSurvivalLYMPH-NODE BIOPSYCORE-NEEDLE-BIOPSYSENTINEL NODEAMERICAN-SOCIETYINVASIVE CANCERMASTECTOMYMORBIDITYDCIS

Identifiers

Scopus EID
2-s2.0-85203793765
WoS UID
001177677200001
KCI
ART003054170